NH Stock Overview
Provides medical and healthcare services in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for NH from our risk checks.
Narayana Hrudayalaya Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,292.30 |
| 52 Week High | ₹1,444.90 |
| 52 Week Low | ₹798.05 |
| Beta | 0.39 |
| 1 Month Change | 4.01% |
| 3 Month Change | -4.32% |
| 1 Year Change | 67.15% |
| 3 Year Change | 196.13% |
| 5 Year Change | 549.23% |
| Change since IPO | 283.53% |
Recent News & Updates
Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation
Apr 09
Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking
Mar 20If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity
Mar 04Recent updates
Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation
Apr 09Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking
Mar 20If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity
Mar 04Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking
Dec 20Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?
Dec 05We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger
Nov 08Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today
Oct 21Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt
Aug 01Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today
Jul 07The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested
Jun 22With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case
Jan 19Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly
Sep 30Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching
Aug 11We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger
Jul 16Returns On Capital Are A Standout For Narayana Hrudayalaya (NSE:NH)
Mar 25Is Narayana Hrudayalaya (NSE:NH) A Risky Investment?
Jan 02A Look At The Intrinsic Value Of Narayana Hrudayalaya Limited (NSE:NH)
Dec 07We Think Narayana Hrudayalaya (NSE:NH) Can Manage Its Debt With Ease
Sep 10We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation
Aug 20Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher
Aug 07Is Narayana Hrudayalaya (NSE:NH) Using Too Much Debt?
Dec 10Shareholder Returns
| NH | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 2.4% | 2.0% | 3.3% |
| 1Y | 67.1% | 53.1% | 44.8% |
Return vs Industry: NH exceeded the Indian Healthcare industry which returned 53.1% over the past year.
Return vs Market: NH exceeded the Indian Market which returned 44.8% over the past year.
Price Volatility
| NH volatility | |
|---|---|
| NH Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: NH has not had significant price volatility in the past 3 months.
Volatility Over Time: NH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 11,923 | Emmanuel Rupert | www.narayanahealth.org |
Narayana Hrudayalaya Limited provides medical and healthcare services in India and internationally. The company acquires, owns, and operates hospitals, clinics, health centers, and nursing homes. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services.
Narayana Hrudayalaya Limited Fundamentals Summary
| NH fundamental statistics | |
|---|---|
| Market cap | ₹262.43b |
| Earnings (TTM) | ₹7.72b |
| Revenue (TTM) | ₹49.69b |
34.0x
P/E Ratio5.3x
P/S RatioIs NH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NH income statement (TTM) | |
|---|---|
| Revenue | ₹49.69b |
| Cost of Revenue | ₹30.95b |
| Gross Profit | ₹18.74b |
| Other Expenses | ₹11.02b |
| Earnings | ₹7.72b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 24, 2024
| Earnings per share (EPS) | 38.00 |
| Gross Margin | 37.71% |
| Net Profit Margin | 15.53% |
| Debt/Equity Ratio | 42.8% |
How did NH perform over the long term?
See historical performance and comparison